Lb Pharmaceuticals (LBRX) Payables (2024 - 2026)

Lb Pharmaceuticals' Payables history runs 3 years deep, the most recent figure standing at $8.3 million for Q1 2026.

• In Q1 2026, Payables changed N/A year-over-year to $8.3 million; the TTM figure through Mar 2026 stood at $8.3 million (changed N/A YoY), while the FY2025 annual figure was $3.5 million, down 28.07% from the prior year.
• Payables for Q1 2026 stood at $8.3 million, up from $3.5 million in the prior quarter.
• The five-year high for Payables was $8.3 million in Q1 2026, with the low at $3.5 million in Q4 2025.
• The 3-year median for Payables is $4.2 million (2024), against an average of $5.0 million.
• Peak annual rise in Payables reached 28.07% in 2025, while the deepest fall reached 28.07% in 2025.
• Lb Pharmaceuticals' Payables stood at $4.8 million in 2024, then fell by 28.07% to $3.5 million in 2025, then jumped by 138.1% to $8.3 million in 2026.
• Business Quant data shows LBRX's Payables at $8.3 million in Q1 2026, $3.5 million in Q4 2025, and $3.5 million in Q3 2025.